Geode Capital Management, LLC Fusion Pharmaceuticals Inc. Transaction History

Geode Capital Management, LLC

  • $1.12 Trillion
  • Q2 2024

Shares

6 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 13, 2024
BUY
$7.9 - $21.32 $20,231 - $54,600
2,561 Added 6.51%
41,907 $893,000
Q4 2023

Feb 13, 2024
BUY
$2.48 - $9.65 $21,025 - $81,812
8,478 Added 27.47%
39,346 $378,000
Q3 2023

Nov 13, 2023
BUY
$2.37 - $4.63 $1,170 - $2,287
494 Added 1.63%
30,868 $80,000
Q2 2023

Aug 11, 2023
BUY
$3.47 - $5.33 $18,175 - $27,918
5,238 Added 20.84%
30,374 $141,000
Q3 2021

Nov 12, 2021
BUY
$7.83 - $9.41 $16,028 - $19,262
2,047 Added 8.87%
25,136 $199,000
Q3 2020

Nov 13, 2020
BUY
$11.8 - $17.1 $272,450 - $394,821
23,089 New
23,089 $277,000

Others Institutions Holding FUSN

# of Institutions
5
Shares Held
93K
Call Options Held
1.4K
Put Options Held
0
View Full List

About Fusion Pharmaceuticals Inc.

FUSN Quotes by TradingView
  • Ticker FUSN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 43,390,500
  • Description
  • Fusion Pharmaceuticals Inc., a clinical-stage oncology company, focuses on developing radiopharmaceuticals as precision medicines. The company has developed Targeted Alpha Therapies platform together with its proprietary Fast-Clear linker technology to enable us to connect alpha particle emitting isotopes to various targeting molecules in order ...
More about FUSN
Track This Portfolio

Track Geode Capital Management, LLC Portfolio

Follow Geode Capital Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Geode Capital Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Geode Capital Management, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email